Reinhorn, Daniel http://orcid.org/0000-0002-7717-9032
Kuchuk, Iryna
Shochat, Tzippy
Nisenbaum, Bella
Sulkes, Aaron
Hendler, Daniel
Rotem, Ofer
Tsoref, Daliah
Olitzky, Olga
Goldvaser, Hadar
Sarfaty, Michal
Neiman, Victoria
Prus, Judit
Gottfried, Maya
Yust-Katz, Shlomit
Yerushalmi, Rinat
Article History
Received: 15 January 2021
Accepted: 16 March 2021
First Online: 27 March 2021
Declarations
:
: Dr. Kuchuk declared <i>honorarium</i> payment from Roche, Pfizer, Novartis, Eli Lilly, all outside the submitted manuscript. Dr. Goldvaser declared <i>honorarium</i> payment from Roche, Pfizer, Novartis, Oncotest, all outside the submitted manuscript. Dr. Yust-Katz declared <i>honorarium</i> payment from Teva, Astra-Zeneca, Novartis and receiving a research grant from BMS. Dr. Yerushalmi reports personal fees from Roche (Consulting, Invited speaker), Pfizer (Consulting), Novartis (Consulting), Teva (Invited speaker), Medison (Invited speaker), Dexel (Consulting), MSD (Invited speaker), Astra-Zeneca (Invited speaker) and Novartis (Invited speaker), all outside the submitted manuscript. The other authors have no conflicts of interest to declare.